SCHEMBL31355365

SCHEMBL31355365

COc1ccc(-c2nc3cnccn3c2Nc2ccc(C(C)C)cc2)cc1OC

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 12/20 0.84
▸ MAPT P10636 12/20 0.84
▸ KDM4E B2RXH2 5/20 0.84
▸ TP53 P04637 4/20 0.84
▸ LMNA P02545 4/20 0.84
▸ NPSR1 Q6W5P4 3/20 0.84
▸ POLB P06746 2/20 0.84
▸ HTT P42858 2/20 0.84
▸ TUBB4A P04350 8/20 0.67
▸ TUBB P07437 8/20 0.67
▸ TUBA3C P0DPH7 8/20 0.67
▸ TUBA1B P68363 8/20 0.67
▸ TUBA4A P68366 8/20 0.67
▸ TUBB4B P68371 8/20 0.67
▸ TUBB3 Q13509 8/20 0.67
▸ TUBB2A Q13885 8/20 0.67
▸ TUBB8 Q3ZCM7 8/20 0.67
▸ TUBA3E Q6PEY2 8/20 0.67
▸ TUBA1A Q71U36 8/20 0.67
▸ TUBA1C Q9BQE3 8/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10016523 0.91 GAA (1.00) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355380 0.90 GAA (0.88) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355268 0.90 GAA (0.84) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355328 0.89 TUBB4A (0.83) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355361 0.85 GAA (0.65) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355350 0.84 GAA (0.67) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355322 0.83 GAA (0.65) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355366 0.81 GAA (0.85) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355345 0.81 GAA (0.80) GAAMAPTKDM4ETP53LMNA
SCHEMBL31355246 0.80 GAA (0.83) GAAMAPTKDM4ETP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250032485-A1 APPLICATION OF IMIDAZO [1,2-A] PYRAZINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS IN THE PREPARATION OF ANTI-CORONAVIRUS DRUGS UNIV GUANGZHOU MEDICAL (CN) 2025-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250032485-A1 APPLICATION OF IMIDAZO [1,2-A] PYRAZINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS IN THE PREPARATION OF ANTI-CORONAVIRUS DRUGS TOP1, TDP1, TOP2A GAA 2008/4885MAPT 2846/4885KDM4E 2246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback